Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 19, 2015 (11 years ago)

Furosemide 20 mg/mL svn Sol

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Furosemide 20 mg/mL svn Sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938

Drug: Furosemide

Recalling firm
Western Drug
Origin
AZ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0405-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Furosemide recalls

See all
Class II · Moderate risk

Furosemide Tablets

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Ongoing Nitrosamine impurity Leading Pharma, LLC NDC 69315-118-01 D-0486-2026
Class II · Moderate risk

Furosemide Tablets USP

Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Terminated Failed specification Roxane Laboratories, Inc. NDC 0054-4297-31 D-0437-2017
Class III · Low risk

FUROSEMIDE Tablets USP

CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.

Terminated cGMP deviation Boehringer Ingelheim Roxane Inc NDC 0054-4299-31 D-0012-2016

Other recalls by Western Drug

All 2015 recalls